VYNE Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $0.2M beats by $0.1M (NASDAQ:VYNE)
VYNE Therapeutics VYNE Therapeutics (US:VYNE) Seeking Alpha·2025-11-06 17:05

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]